14 Multiple Sclerosis Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Multiple Sclerosis Studies in San Francisco

NCT01750619Recruiting

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative end...

San Francisco, CA8,000 participantsCalifornia Pacific Medical Center Research Institute

View Study Details

NCT06486454Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient charac...

San Francisco, CA5,000 participantsHistoSonics, Inc.

View Study Details

NCT00756665Recruiting

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close mo...

San Francisco, CA3,000 participantsUniversity of Washington

View Study Details

NCT07585266Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

Gastrointestinal Stromal Tumour (GIST) is a soft tissue tumour that develops in the digestive system, most often in the stomach or small intestine. It is caused by changes in certain proteins that cau...

San Francisco, CAPHASE3800 participantsGlaxoSmithKline

View Study Details

NCT07218926Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

The purpose of this study is to find out if a new drug, called IDRX-42 (also known as GSK6042981), is effective in treating adults with a type of cancer called Gastrointestinal Stromal Tumors (GIST) w...

San Francisco, CAPHASE3450 participantsGlaxoSmithKline

View Study Details

NCT07222618Recruiting

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators...

San Francisco, CA300 participantsUniversity of California, San Francisco

View Study Details

NCT07011914Recruiting

Care in Multiple Sclerosis (MS)

This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversit...

San Francisco, CA300 participantsNYU Langone Health

View Study Details

NCT06751329Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

The goal of study： The study has two parts: Part 1 Dose Escalation and Part 2 Dose Expansion. In Part 1, a few participants will receive the lowest dose of study drug. The study team will make sure ...

San Francisco, CAPHASE1280 participantsXadcera Biopharmaceutical (Suzhou) Co., Ltd.

View Study Details

NCT07339176Recruiting

Intratumoral N17350 in Advanced Solid Tumors

The goal of this clinical trial is to learn if N17350 works to treat advanced solid tumors in adults. It will also learn about the safety of N17350 and help determine the best dose to use in future st...

San Francisco, CAPHASE1275 participantsOnchilles Pharma Inc

View Study Details

NCT04794322Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

The study aims to develop a test for early detection of ovarian cancer using DNA from a growth involving the ovary found in a washing of the uterus (womb), and proteins found in the blood. The samples...

San Francisco, CA250 participantsMassachusetts General Hospital

View Study Details

NCT06940323Recruiting

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

PRISMA, is a pregnancy registry study, focused on comprehensively collecting information about pregnancy in women with chronic neurological conditions from across the United States and internationally...

San Francisco, CA250 participantsUniversity of California, San Francisco

View Study Details

NCT05359653Recruiting

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

The clinical trial is intended to assess for clinical evidence of Clemastine Fumarate as a myelin repair therapy in patients with chronic inflammatory injury-causing demyelination as measured by multi...

San Francisco, CAPHASE174 participantsUniversity of California, San Francisco

View Study Details

NCT07421596Recruiting

An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System

This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period. Gut and digestive health play a...

San Francisco, CANA50 participantsSF Research Institute, Inc.

View Study Details

NCT07510607Recruiting

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

The main purpose of this study is to assess whether hyperpolarized carbon imaging in relapsing remitting multiple sclerosis (MS) patients can be used to predict response to anti-CD20 disease modifying...

San Francisco, CAPHASE240 participantsAri Green

View Study Details

About Multiple Sclerosis Clinical Trials in San Francisco

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 14 multiple sclerosis clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 19,069 participants. Research is being sponsored by California Pacific Medical Center Research Institute, HistoSonics, Inc., University of Washington and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in San Francisco — FAQ

Are there multiple sclerosis clinical trials in San Francisco?

Yes, there are 14 multiple sclerosis clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 14 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated October 16, 2026 from ClinicalTrials.gov